Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 15Recruiting 6Unknown 5Terminated 5Withdrawn 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 37Colorectal Neoplasms 28Leukemia, Myeloid, Acute 27Neoplasms 26Recurrence 22Neoplasm Metastasis 22Multiple Myeloma 20Advanced Solid Tumors 20Lymphoma, B-Cell 19Breast Neoplasms 17Pancreatic Neoplasms 14Lung Neoplasms 13Glioblastoma 13Carcinoma, Hepatocellular 13Brain Neoplasms 13Lymphoma 12Glioma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Melanoma 11Hematologic Neoplasms 11Triple Negative Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Leukemia 10Advanced Solid Tumor 10Prostatic Neoplasms 9Head and Neck Neoplasms 9Lymphoma, Non-Hodgkin 8Esophageal Neoplasms 8Sarcoma 7

Interventions

repaglinide 1drospirenone 1Midazolam 1Ethinyl Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Advanced Malignancies × Clear all
NCT07340190 2026-04-02

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Novartis

Phase 1 Not yet recruiting
24 enrolled

Advanced Malignancies

NCT06206915 2024-01-16

Phase I Study of XZ120 in Malignant Tumors

Shandong New Time Pharmaceutical Co., LTD

Phase 1 Not yet recruiting
123 enrolled

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡